Senseonics to Present at the Stifel 2022 Healthcare Conference
09 Novembre 2022 - 10:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS) a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced plans to participate in
the upcoming Stifel Healthcare Conference in New York, NY.
Management is scheduled to participate on Tuesday, November 15,
2022 at 11:30am ET and will hold one-on-one meetings following.
Interested parties can access a live and recorded webcast
presentation directly by following this link. An archived webcast
of the presentation will be available on the “Investors” section of
the company’s website at www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company
focused on the development and manufacturing of glucose monitoring
products designed to transform lives in the global diabetes
community with differentiated, long-term implantable glucose
management technology. Senseonics' CGM systems, Eversense®,
Eversense® XL and Eversense® E3 include a small sensor inserted
completely under the skin that communicates with a smart
transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221109005807/en/
Senseonics Investor Contact Philip Taylor Investor
Relations 415-937-5406 investors@senseonics.com
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024